Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Tango Therapeutics Inc (TNGX)

191 + Investors. Track Smart Money conviction in TNGX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +24
Streak
3Q ▲
Buyers last Q
57%

Smart Money Signals — TNGX

Based on 192 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added TNGX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
192 hedge funds hold TNGX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +60% more funds vs a year ago

fund count last 6Q
+72 new funds entered over the past year (+60% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 57% buying

121 buying92 selling
Last quarter: 121 funds bought or added vs 92 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~58 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 22 → 38 → 53 → 58. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 34% long-term, 39% new

■ 34% conviction (2yr+) ■ 27% medium ■ 39% new
Of the 192 current holders: 66 (34%) held >2 years, 52 held 1–2 years, and 74 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +144% but shares only +5% — price-driven

Value
+144%
Shares
+4%
Last quarter: the total dollar value of institutional holdings rose +144%, but actual share count only changed +5%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

17 → 22 → 38 → 53 → 58 new funds/Q
New funds entering each quarter: 22 → 38 → 53 → 58. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 46% veterans vs 38% newcomers

■ 46% veterans ■ 16% 1-2yr ■ 38% new
Entry-cohort mix of 196 holders: 90 (46%) are 2+ year veterans, 31 entered 1–2 years ago, and 75 (38%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
47 of 191 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.8
out of 10
Moderate Exit Risk
Exit risk score 4.8/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TNGX

In 2026 Q1, 121 hedge funds were net buyers of TNGX (58 opened a new position, 63 added to an existing one), while 92 reduced or exited (58 trimmed, 34 sold completely) — a 57% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 24% of total institutional value in TNGX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +24 funds (more new holders than closures). Total institutional holders: 192.

Hedge Fund Ownership: TNGX

How many hedge funds hold TNGX — quarterly history vs. share price
Quarterly hedge fund ownership of TNGX vs. share price

Market Analysis: TNGX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TNGX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Tango Therapeutics Inc (TNGX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TNGX has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 47d ago
TNGX
-18.1%
XLV
+5.5%

TNGX outperformed XLV by -23.6% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 2d ago
TNGX
+0.0%
XLV
+0.0%

Since the filing became public, TNGX outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

21 top-rated funds 12 high-conviction
Consensus
5.8
/ 10
breadth
×
Elite
4.7
/ 10
conviction
Hedge Fund Positioning: TNGX
2026 Q2 Stats Unlock in 3 days 191 + Investors

Track Smart Money conviction in TNGX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 191 167 14.37%
13F Shares 180M 172M 4.56%
Total Value $3.73B $1.53B 144.05%
New Positions 57 52 +5
Increased Positions 63 74 -11
Closed Positions 33 26 +7
Reduced Positions 56 27 +29
Total Calls 2 2 -
Total Puts 3 1 200.0%
PUT/CALL Ratio 1.5 0.5 Bearish

Statistics: TNGX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

191 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TNGX. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 TNGX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Trv GP IV, LLC 47.37% 6,374,574 $120.2M
2 Boxer Capital Management, LLC 25.61% 10,876,219 $340.0M
3 Acuta Capital Partners, LLC 8.52% 390,949 $12.2M
4 TCG Crossover Management, LLC 6.82% 9,081,201 $283.9M
5 Stempoint Capital LP 6.59% 1,223,019 $38.2M
6 Dv Equities, LLC 5.91% 1,318,551 $41.2M
7 KVP Capital Advisors, LP 5.28% 230,264 $7.2M
8 Monashee Investment Management LLC 5.25% 100,000 $3.1M
9 Commodore Capital LP 4.19% 2,250,000 $70.3M
10 Vivo Capital, LLC 3.94% 1,379,769 $43.1M
11 Siren, L.L.C. 3.91% 6,179,364 $193.2M
12 Logos Global Management LP 3.84% 2,850,000 $89.1M
13 Paradigm Biocapital Advisors LP 3.72% 6,357,523 $198.7M
14 Rtw Investments, LP 3.71% 13,900,620 $434.5M
15 Caligan Partners LP 3.68% 2,500,103 $78.2M
16 Boone Capital Management LLC 3.33% 455,605 $14.2M
17 Mass General Brigham, Inc 3.07% 354,192 $11.1M
18 Trv GP VI, LLC 2.61% 194,174 $6.1M
19 Cormorant Asset Management, LP 2.08% 1,300,000 $40.6M
20 Deep Track Capital, LP 1.91% 4,200,000 $131.3M
21 HighVista Strategies LLC 1.85% 260,070 $8.1M
22 Atle Fund Management AB 1.67% 198,557 $6.2M
23 Perceptive Advisors LLC 1.58% 3,377,000 $105.6M
24 Deerfield Management Company, L.P. 1.37% 4,190,611 $131.0M
25 Integral Health Asset Management, LLC 1.23% 1,000,000 $31.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Tango Therapeutics Inc (TNGX)

What does the Smart Money Trend signal show for TNGX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added TNGX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TNGX?

Slight buying edge — 57% buying: Last quarter: 121 funds bought or added vs 92 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TNGX holders?

Strong quality — 24% AUM from major funds: 47 of 191 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TNGX?

Mixed — 34% long-term, 39% new: Of the 192 current holders: 66 (34%) held >2 years, 52 held 1–2 years, and 74 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Tango Therapeutics Inc (TNGX) following the 2026 Q2 hedge fund 13F filings?

As of today, TNGX has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), TNGX has gained -18.1% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →